« Previous | Next » | All Messages |  SHPI Message Board Home | recommend post |  Ignore Poster

SHPI News Specialized Health Products Ranked Number 152 Fastest Growing Company in North America on Deloitte's 2006 Technology Fast 500

BOUNTIFUL, Utah--(BUSINESS WIRE)--Specialized Health Products International, Inc. (“SHPI”) (OTCBB: SHPI) today announced that it ranked Number 152 on Deloitte’s 2006 Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications and life sciences companies in North America. Rankings are based on percentage revenue growth over five years, from 2001–2005. Specialized Health Products International, Inc. grew 1,243% percent during this period.

SHPI’s President and CEO, Jeff Soinski, credits the company’s rapid pace of new safety needle product introductions and the success of its manufactured product lines with the company’s 1,243% revenue growth over the past five years. He said, "As a company, we have committed ourselves to developing innovative safety medical products that meet clinician and patient needs. Based upon the success of these products, it is an honor to be recognized for the second year in a row as one of the fastest growing technology companies in North America."

"Making Deloitte’s Technology Fast 500 is commendable in today’s highly competitive technology industry," said Tony Kern, deputy managing principal of Deloitte’s Technology, Media & Telecommunications industry practice. "We congratulate Specialized Health Products on being one of the 500 fastest growing technology companies in North America."

Specialized Health Products International, Inc. previously ranked Number 211 on Deloitte’s 2005 Technology Fast 500.

Fast 500 Selection and Qualifying Criteria

The Fast 500 ranks the fastest growing technology, media, telecommunications and life sciences companies in North America. It is compiled from Deloitte’s 16 regional North American Fast 50 programs, nominations submitted directly to the Fast 500, and public company database research. Companies are selected based on percentage revenue growth from 2001 to 2005.

Entrants must own proprietary intellectual property or proprietary technology that contributes to a significant portion of the company's operating revenues or devote a significant proportion of revenues to research and development of technology. Using other companies' technology or intellectual property in a unique way does not qualify. Base-year operating revenues must be at least $50,000 USD or $75,000 CD, and current-year operating revenues must be at least $5 million USD or CD. Companies must be in business a minimum of five years, and they must be headquartered within North America.

About Specialized Health Products International, Inc.

Specialized Health Products International, Inc. (“SHPI”) is a leading developer, manufacturer and marketer of proprietary disposable medical devices for clinician and patient safety. SHPI has developed multiple safety needle products based upon a broad intellectual property portfolio that applies to virtually all medical needles used today. SHPI manufactures and markets certain products, including three of the leading brands in the safety Huber needle market, under its own label. It licenses or supplies other products to leading manufacturers and marketers in the global disposable medical products industry, including Tyco Healthcare, Bard Access Systems, and BD Medical. In June 2006, SHPI merged with The Med-Design Corporation, another leading technology provider in the safety medical needle space. For more information about SHPI, visit the company’s website at www.shpi.com.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms, and their respective subsidiaries and affiliates. Deloitte Touche Tohmatsu is an organization of member firms around the world devoted to excellence in providing professional services and advice, focused on client service through a global strategy executed locally in nearly 150 countries. With access to the deep intellectual capital of approximately 135,000 people worldwide, Deloitte delivers services in four professional areas—audit, tax, consulting and financial advisory services—and serves more than one-half of the world’s largest companies, as well as large national enterprises, public institutions, locally important clients, and successful, fast-growing global growth companies. Services are not provided by the Deloitte Touche Tohmatsu Verein, and, for regulatory and other reasons, certain member firms do not provide services in all four professional areas.

As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other’s acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names “Deloitte”, “Deloitte & Touche”, “Deloitte Touche Tohmatsu”, or other related names.

In the United States, Deloitte & Touche USA LLP is the member firm of Deloitte Touche Tohmatsu, and services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP, and their subsidiaries), and not by Deloitte & Touche USA LLP. The subsidiaries of the U.S. member firm are among the nation's leading professional services firms, providing audit, tax, consulting, and financial advisory services through nearly 40,000 people in more than 90 cities. Known as an employer of choice for innovative human resources programs, it is dedicated to helping their clients and their people excel. For more information, please visit the U.S. member firm’s Web site at www.deloitte.com/us.

This news release contains forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The Company may experience significant fluctuations in future operating results due to a number of economic conditions, risks in product and technology development, the effect of the Company's accounting policies and other risk factors detailed in the Company's SEC filings. These factors and others could cause operating results to vary significantly from those in prior periods and those projected in forward-looking statements. Additional information with respect to these and other factors, which could materially affect the Company and its operations, are included on certain forms the Company files with the Securities and Exchange Commission.